Cancer drugs that received accelerated approval from the FDA gained regular approval significantly faster if their ...

Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be ...

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this ...

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

Following a positive readout for its closely watched PD-1xVEGF bispecific ivonescimab, Akeso has won the FDA’s go-ahead for ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have ...

A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left ...

The frequency of high blood glucose among patients receiving PI3K/Akt inhibitors to treat breast cancer has some oncologists ...